246 related articles for article (PubMed ID: 18483189)
1. Classification of childhood white matter disorders using proton MR spectroscopic imaging.
Bizzi A; Castelli G; Bugiani M; Barker PB; Herskovits EH; Danesi U; Erbetta A; Moroni I; Farina L; Uziel G
AJNR Am J Neuroradiol; 2008 Aug; 29(7):1270-5. PubMed ID: 18483189
[TBL] [Abstract][Full Text] [Related]
2. In vivo quantitative proton MRSI study of brain development from childhood to adolescence.
Horská A; Kaufmann WE; Brant LJ; Naidu S; Harris JC; Barker PB
J Magn Reson Imaging; 2002 Feb; 15(2):137-43. PubMed ID: 11836768
[TBL] [Abstract][Full Text] [Related]
3. Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease.
Pizzini F; Fatemi AS; Barker PB; Nagae-Poetscher LM; Horská A; Zimmerman AW; Moser HW; Bibat G; Naidu S
AJNR Am J Neuroradiol; 2003 Sep; 24(8):1683-9. PubMed ID: 13679292
[TBL] [Abstract][Full Text] [Related]
4. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
5. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.
Wiedermann D; Schuff N; Matson GB; Soher BJ; Du AT; Maudsley AA; Weiner MW
Magn Reson Imaging; 2001 Oct; 19(8):1073-80. PubMed ID: 11711231
[TBL] [Abstract][Full Text] [Related]
6. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
[TBL] [Abstract][Full Text] [Related]
7. Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy.
Achten E; Boon P; Van De Kerckhove T; Caemaert J; De Reuck J; Kunnen M
AJNR Am J Neuroradiol; 1997; 18(6):1131-9. PubMed ID: 9194441
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
9. Neurochemistry in shiverer mouse depicted on MR spectroscopy.
Takanashi J; Nitta N; Iwasaki N; Saito S; Tanaka R; Barkovich AJ; Aoki I
J Magn Reson Imaging; 2014 Jun; 39(6):1550-7. PubMed ID: 24243812
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
[TBL] [Abstract][Full Text] [Related]
11. Developmental delay in children: assessment with proton MR spectroscopy.
Filippi CG; Uluğ AM; Deck MD; Zimmerman RD; Heier LA
AJNR Am J Neuroradiol; 2002 May; 23(5):882-8. PubMed ID: 12006297
[TBL] [Abstract][Full Text] [Related]
12. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
[TBL] [Abstract][Full Text] [Related]
13. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
[TBL] [Abstract][Full Text] [Related]
15. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.
Schuff N; Ezekiel F; Gamst AC; Amend DL; Capizzano AA; Maudsley AA; Weiner MW
Magn Reson Med; 2001 May; 45(5):899-907. PubMed ID: 11323817
[TBL] [Abstract][Full Text] [Related]
16. Can proton MR spectroscopic and perfusion imaging differentiate between neoplastic and nonneoplastic brain lesions in adults?
Hourani R; Brant LJ; Rizk T; Weingart JD; Barker PB; Horská A
AJNR Am J Neuroradiol; 2008 Feb; 29(2):366-72. PubMed ID: 18055564
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging.
Boesch SM; Wolf C; Seppi K; Felber S; Wenning GK; Schocke M
J Magn Reson Imaging; 2007 Mar; 25(3):564-9. PubMed ID: 17326083
[TBL] [Abstract][Full Text] [Related]
18. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
20. MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.
Willemsen MA; Van Der Graaf M; Van Der Knaap MS; Heerschap A; Van Domburg PH; Gabreëls FJ; Rotteveel JJ
AJNR Am J Neuroradiol; 2004 Apr; 25(4):649-57. PubMed ID: 15090362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
